This HTML5 document contains 8 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Subject Item

n2:

rdfs:label

Insulin detemir

rdfs:comment

Insulin detemir (brand name: Levemir[1]) is a long-acting insulin developed by Novo Nordisk. Levemir is used to maintain the basal level of insulin, and can provide up to 24 hours of blood sugar control, though more commonly closer to 12 hours of coverage. It is typically dosed twice a day. The duration of action is dependent on the dose, with higher doses remaining in the body longer. Levemir cannot be mixed with other insulins. Levemir is available in vials for injection, or with a Levemir FlexPen.

owl:sameAs

dbr:Insulin_detemir

dcterms:subject

n5:

n12:

7200.0

n8:wikiPageUsesTemplate

n9:

n6:

-86400.0

n3:abstract

Insulin detemir (brand name: Levemir[1]) is a long-acting insulin developed by Novo Nordisk. Levemir is used to maintain the basal level of insulin, and can provide up to 24 hours of blood sugar control, though more commonly closer to 12 hours of coverage. It is typically dosed twice a day. The duration of action is dependent on the dose, with higher doses remaining in the body longer. Levemir cannot be mixed with other insulins. Levemir is available in vials for injection, or with a Levemir FlexPen.